Bloomberg News

BiolineRx Jumps Most in 3 Months After Reporting Test Results

December 07, 2011

Dec. 6 (Bloomberg) -- BioLineRx Ltd. soared the most in almost three months after it said that the trial of its neuropathic pain molecule had “positive” results.

The shares jumped 11 percent, the biggest intraday gain since Sept. 14, to 1.333 shekels at 11:08 a.m. in Tel Aviv.

To contact the reporter on this story: Gwen Ackerman in Jerusalem at gackerman@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net


Race, Class, and the Future of Ferguson
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus